ID   AT8BI LCL
AC   CVCL_7322
SY   Ataxia Telangiectasia 8 BIrmingham LCL; GM01526; GM-1526; GM 1526; GM1526; GM01526B; GM-1526B; GM01526C
DR   CLO; CLO_0031476
DR   BioSample; SAMN00806894
DR   BioSample; SAMN03472405
DR   Coriell; GM01526
DR   JCRB; JCRB3008
DR   JCRB; KURB3012
DR   Wikidata; Q54836883
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
RX   PubMed=1561323;
RX   PubMed=6228733;
RX   PubMed=6504056;
RX   PubMed=7539412;
RX   PubMed=16166284;
RX   PubMed=29892436;
CC   HLA typing: A*09,10; B*w17,13(w40) (Coriell).
CC   Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000187275; Zygosity=Unspecified (Coriell).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; KURB3012; probable.
CC   Derived from sampling site: Peripheral blood.
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_B5MB ! AT8BI
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 17-03-22; Version: 22
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   DOI=10.5962/bhl.title.4090;
RA   Coriell L.L., Greene A.E.;
RT   "The human genetic mutant cell repository: list of genetic variants,
RT   chromosomal aberrations and normal cell cultures submitted to the
RT   repository. 4th edition. October 1977.";
RL   (In) Institute for Medical Research (Camden, N.J.); pp.1-171; National Institutes of Health; Bethesda (1977).
//
RX   PubMed=761484; DOI=10.1159/000131301;
RA   Cohen M.M., Sagi M., Ben-Zur Z., Schaap T., Voss R., Kohn G.,
RA   Ben-Bassat H.;
RT   "Ataxia telangiectasia: chromosomal stability in continuous
RT   lymphoblastoid cell lines.";
RL   Cytogenet. Cell Genet. 23:44-52(1979).
//
RX   PubMed=1561323; DOI=10.2307/3578485;
RA   Pandita T.K., Hittelman W.N.;
RT   "Initial chromosome damage but not DNA damage is greater in ataxia
RT   telangiectasia cells.";
RL   Radiat. Res. 130:94-103(1992).
//
RX   PubMed=6228733; DOI=10.1016/0167-8817(83)90030-5;
RA   Imray F.P., Kidson C.;
RT   "Perturbations of cell-cycle progression in gamma-irradiated ataxia
RT   telangiectasia and Huntington's disease cells detected by DNA flow
RT   cytometric analysis.";
RL   Mutat. Res. 112:369-382(1983).
//
RX   PubMed=6504056; DOI=10.1016/0027-5107(84)90149-0;
RA   Chen P., Imray F.P., Kidson C.;
RT   "Gene dosage and complementation analysis of ataxia telangiectasia
RT   lymphoblastoid cell lines assayed by induced chromosome
RT   aberrations.";
RL   Mutat. Res. 129:165-172(1984).
//
RX   PubMed=7539412; DOI=10.1002/ijc.2910610524;
RA   Pandita T.K., Hittelman W.N.;
RT   "Evidence of a chromatin basis for increased mutagen sensitivity
RT   associated with multiple primary malignancies of the head and neck.";
RL   Int. J. Cancer 61:738-743(1995).
//
RX   PubMed=16166284; DOI=10.1158/0008-5472.CAN-04-1198;
RA   Araten D.J., Golde D.W., Zhang R.H., Thaler H.T., Gargiulo L.,
RA   Notaro R., Luzzatto L.;
RT   "A quantitative measurement of the human somatic mutation rate.";
RL   Cancer Res. 65:8111-8117(2005).
//
RX   PubMed=29892436; DOI=10.1098/rsos.172472;
RA   Shioda S., Kasai F., Watanabe K., Kawakami K., Ohtani A., Iemura M.,
RA   Ozawa M., Arakawa A., Hirayama N., Kawaguchi E., Tano T., Miyata S.,
RA   Satoh M., Shimizu N., Kohara A.;
RT   "Screening for 15 pathogenic viruses in human cell lines registered at
RT   the JCRB Cell Bank: characterization of in vitro human cells by viral
RT   infection.";
RL   R. Soc. Open Sci. 5:172472-172472(2018).
//